Market closed
MediWound Ltd./$MDWD
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About MediWound Ltd.
MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.
Ticker
$MDWD
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Yavne, Israel
Employees
111
Website
MediWound Ltd. Metrics
BasicAdvanced
$173M
-
-$3.03
0.82
-
Price and volume
Market cap
$173M
Beta
0.82
52-week high
$19.68
52-week low
$14.71
Financial strength
Current ratio
1.965
Quick ratio
1.864
Long term debt to equity
20.906
Total debt to equity
22.248
Interest coverage (TTM)
-1.80%
Management effectiveness
Return on assets (TTM)
-17.33%
Return on equity (TTM)
-96.33%
Valuation
Price to revenue (TTM)
7.88
Price to book
5.54
Price to tangible book (TTM)
5.56
Price to free cash flow (TTM)
-8.009
Growth
Revenue change (TTM)
8.22%
Earnings per share change (TTM)
307.26%
3-year revenue growth (CAGR)
-5.24%
3-year earnings per share growth (CAGR)
-4.48%
MediWound Ltd. News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for MediWound Ltd. stock?
MediWound Ltd. (MDWD) has a market cap of $173M as of April 05, 2025.
What is the P/E ratio for MediWound Ltd. stock?
The price to earnings (P/E) ratio for MediWound Ltd. (MDWD) stock is 0 as of April 05, 2025.
Does MediWound Ltd. stock pay dividends?
No, MediWound Ltd. (MDWD) stock does not pay dividends to its shareholders as of April 05, 2025.
When is the next MediWound Ltd. dividend payment date?
MediWound Ltd. (MDWD) stock does not pay dividends to its shareholders.
What is the beta indicator for MediWound Ltd.?
MediWound Ltd. (MDWD) has a beta rating of 0.82. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.